{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:36:01Z","timestamp":1789803361878,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,3,10]],"date-time":"2005-03-10T00:00:00Z","timestamp":1110412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00259-005-1769-0","type":"journal-article","created":{"date-parts":[[2005,3,9]],"date-time":"2005-03-09T13:51:50Z","timestamp":1110376310000},"page":"788-793","source":"Crossref","is-referenced-by-count":7,"title":["The route of administration (oral vs intravenous) does not influence dose or outcome in Graves\u2019 disease and unifocal autonomy"],"prefix":"10.1007","volume":"32","author":[{"given":"Peter","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Biko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"H\u00e4nscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Hilliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Koutsampelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kranzfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Reiners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,3,10]]},"reference":[{"key":"1769_CR1","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s002590100565","volume":"28","author":"C K\u00f6rber","year":"2001","unstructured":"K\u00f6rber C, Schneider P, K\u00f6rber-Hafner N, H\u00e4nscheid H, Reiners C. Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves\u2019 disease and toxic nodular goitre?. Eur J Nucl Med 2001;28:1360\u20134.","journal-title":"Eur J Nucl Med"},{"key":"1769_CR2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/oxfordjournals.rpd.a006233","volume":"105","author":"P Fritsch","year":"2003","unstructured":"Fritsch P, Champio C, Menetrier F, Delforge J. Uncertainties on the committed equivalent dose to the thyroid as a function of age for different iodine isotopes. Radiat Prot Dosimetry 2003;105:247\u201350.","journal-title":"Radiat Prot Dosimetry"},{"key":"1769_CR3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/108497803322285233","volume":"18","author":"H Jonsson","year":"2003","unstructured":"Jonsson H, Mattsson S. Single uptake measurement for absorbed dose planning for radioiodide treatment of hyperthyroidism. Cancer Biother Radiopharm 2003;18:473\u20139.","journal-title":"Cancer Biother Radiopharm"},{"key":"1769_CR4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/108497803322285206","volume":"18","author":"L Johansson","year":"2003","unstructured":"Johansson L, Leide-Svegborn S, Mattsson S, Nosslin B. Biokinetics of iodide in man: refinement of current ICRP dosimetry models. Cancer Biother Radiopharm 2003;18:445\u201350.","journal-title":"Cancer Biother Radiopharm"},{"key":"1769_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/105072503321669802","volume":"13","author":"LF Morris","year":"2003","unstructured":"Morris LF, Waxman AD, Braunstein GD. Thyroid stunning. Thyroid 2003;13:333\u201340.","journal-title":"Thyroid"},{"key":"1769_CR6","first-page":"56","volume":"43","author":"MD Yu","year":"2002","unstructured":"Yu MD, Huang WS, Cherng CC, Shaw SM. The effect of formulation on reduced radioiodide thyroid uptake. J Nucl Med 2002;43:56\u201360.","journal-title":"J Nucl Med"},{"key":"1769_CR7","first-page":"1229","volume":"84","author":"O Sabri","year":"1999","unstructured":"Sabri O, Zimny M, Schulz G, Schreckenberger M, Reinartz P, Willmes K, et al. Success rate of radioiodine therapy in Graves\u2019 disease: the influence of thyrostatic medication. J Clin Endocrinol Metab 1999;84:1229\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"1769_CR8","first-page":"N25","volume":"39","author":"D Moka","year":"2000","unstructured":"Moka D, Schicha H, K\u00f6rber C, Schneider P, Reiners C. Reduced antithyroid agents as a result of radioiodine therapy?. Nuklearmedizin 2000;39:N25\u2013N26.","journal-title":"Nuklearmedizin"},{"key":"1769_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0038-1629866","volume":"36","author":"D Moka","year":"1995","unstructured":"Moka D, Voth E, Schicha H. Effect of ATD on effective half-life and uptake of 131-iodine following radioiodine therapy. Nuklearmedizin 1995;36:87\u201392.","journal-title":"Nuklearmedizin"},{"key":"1769_CR10","first-page":"507","volume":"14","author":"S Halpern","year":"1973","unstructured":"Halpern S, Alazraki N, Littenberg R, Hurwitz S, Green J, Kunsa J, et al. 131I thyroid uptakes: capsules versus liquid. J Nucl Med 1973;14:507\u201310.","journal-title":"J Nucl Med"},{"key":"1769_CR11","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.2460\/ajvr.1994.55.12.1734","volume":"55","author":"AP Theon","year":"1994","unstructured":"Theon AP, Van Vechten MK, Feldamnn E. Prospective randomized comparison of intravenous versus subcutaneous administration of radioiodine for treatment or hyperthyroidism in cats. Am J Vet Res 1994;55:1734\u20138.","journal-title":"Am J Vet Res"},{"key":"1769_CR12","doi-asserted-by":"crossref","first-page":"A80","DOI":"10.1055\/s-0038-1625301","volume":"42","author":"P Andermann","year":"2003","unstructured":"Andermann P, Schl\u00f6gl S, Luster M, Lassmann M, Reiners C. Evaluierung der Interobserver-Variabilit\u00e4t bei der Schilddr\u00fcsensonographie im Vergleich zur 3D-Ultraschall-Referenzmessung. Nuklearmedizin 2003;42:A80.","journal-title":"Nuklearmedizin"},{"key":"1769_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0038-1625308","volume":"42","author":"M Dietlein","year":"2003","unstructured":"Dietlein M, Dressler J, Eschner W, Lassmann M, Leisner B, Reiners C, et al. Procedure Guideline for Radioiodine Test (accessible at: http:\/\/www.schattauer.com\/zs\/nukl\/2003\/3\/pdf\/03030116.pdf). Nuklearmedizin 2003;42:116\u20139.","journal-title":"Nuklearmedizin"},{"key":"1769_CR14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/thy.1999.9.347","volume":"9","author":"J Rini","year":"1999","unstructured":"Rini J, Vallabhajosula S, Zanzonico P, Hurley JR, Becker DV, Goldsmith SJ. Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I. Thyroid 1999;9:347\u201352.","journal-title":"Thyroid"},{"key":"1769_CR15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00006231-200007000-00002","volume":"21","author":"J Van Isselt","year":"2000","unstructured":"Van Isselt J, De Klerk J, Koppeschaar H, Van Rijk P. Iodine-131 uptake and turnover rate vary over short intervals in Graves\u2019 disease. Nucl Med Commun 2000;21:609\u201316.","journal-title":"Nucl Med Commun"},{"key":"1769_CR16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/thy.1997.7.247","volume":"7","author":"H Peters","year":"1997","unstructured":"Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Treatment of Graves\u2019 hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid 1997;7:247\u201351.","journal-title":"Thyroid"},{"key":"1769_CR17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2362.1995.tb01547.x","volume":"25","author":"H Peters","year":"1995","unstructured":"Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Radioiodine therapy of Graves\u2019 hyperthyroidism: standard vs. calculated 131I-iodine activity. Results from a prospective, randomized, multicenter study. Eur J Clin Invest 1995;25:186\u201393.","journal-title":"Eur J Clin Invest"},{"key":"1769_CR18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/00006231-200312000-00008","volume":"24","author":"P Reinartz","year":"2003","unstructured":"Reinartz P, Zimny M, Schaffer W, M\u00fcller B, B\u00fcll U, Sabri O. Radioiodine therapy in patients with hyperthyroid disorder: standard versus dosimetric activity application. Nucl Med Commun 2003;24:1247\u201353.","journal-title":"Nucl Med Commun"},{"key":"1769_CR19","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jc.2002-020805","volume":"88","author":"W Leslie","year":"2003","unstructured":"Leslie W, Ward L, Salomon EA, Ludwig S, Rowe RC, Cowden EA. A randomized comparison of radioiodine doses in Graves\u2019 hyperthyroidism. J Clin Edocrinol Metab 2003;88:978\u201383.","journal-title":"J Clin Edocrinol Metab"},{"key":"1769_CR20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00259-002-0877-3","volume":"29","author":"MJ Reinhardt","year":"2002","unstructured":"Reinhardt MJ, Brink I, Joe AY, Von Mallek D, Ezziddin S, Palmedo H, et al. Radioiodide therapy in Graves\u2019 disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome. Eur J Nucl Med 2002;29:1118\u201324.","journal-title":"Eur J Nucl Med"},{"key":"1769_CR21","first-page":"4012","volume":"84","author":"VA Andrade","year":"1999","unstructured":"Andrade VA, Gross JL, Maia AL. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves\u2019 hyperthyroidism. J Clin Endocrinol Metab 1999;84:4012\u201316.","journal-title":"J Clin Endocrinol Metab"},{"key":"1769_CR22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1530\/eje.0.1320550","volume":"132","author":"M Reinhardt","year":"1995","unstructured":"Reinhardt M, Emrich D, Krause T, Br\u00e4utigam P, Nitsche E, Blattmann H, et al. Improved dose concept for radioiodide therapy of multifocal and disseminated functional thyroid autonomy. Eur J Endocrinol 1995;132:550\u20136.","journal-title":"Eur J Endocrinol"},{"key":"1769_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1632236","volume":"39","author":"C K\u00f6rber","year":"2000","unstructured":"K\u00f6rber C, Schneider P, H\u00e4nscheid H, K\u00f6ck PR, Reiners C. Reliability of posttherapeutic dosimetry of patients with short-time hospitalisation after radioiodine therapy. Nuklearmedizin 2000;39:1\u20134.","journal-title":"Nuklearmedizin"},{"key":"1769_CR24","first-page":"228","volume":"37","author":"GEB Berg","year":"1996","unstructured":"Berg GEB, Michanek AMK, Holmberg ECV, Fink M. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med 1996;37:228\u201332.","journal-title":"J Nucl Med"},{"key":"1769_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/oxfordjournals.rpd.a006531","volume":"95","author":"AC Traino","year":"2001","unstructured":"Traino AC, Di Martino F, Lazzeri M, Stabin MG. Study of the correlation between administered activity and radiation committed dose to the thyroid in 131I therapy of Graves\u2019 disease. Radiat Prot Dosimetry 2001;95:117\u201324.","journal-title":"Radiat Prot Dosimetry"},{"key":"1769_CR26","first-page":"219","volume":"38","author":"M Dietlein","year":"1999","unstructured":"Dietlein M, Dressler J, Joseph K, Leisner B, Moser E, Reiners C, et al. Leitlinie zur Radioiodtherapie bei benignen Schilddr\u00fcsenerkrankungen. Nuklearmedizin 1999;38:219\u201320.","journal-title":"Nuklearmedizin"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-005-1769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-005-1769-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-005-1769-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T12:25:36Z","timestamp":1735215936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-005-1769-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,10]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["1769"],"URL":"https:\/\/doi.org\/10.1007\/s00259-005-1769-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,10]]}}}